LEFLUNOMIDE CH leflunomide 100mg tablet blister pack

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

leflunomide, Quantity: 100 mg

Disponible depuis:

Southern Cross Pharma Pty Ltd

DCI (Dénomination commune internationale):

Leflunomide

forme pharmaceutique:

Tablet, film coated

Composition:

Excipient Ingredients: microcrystalline cellulose; povidone; colloidal anhydrous silica; crospovidone; maize starch; lactose monohydrate; magnesium stearate; titanium dioxide; hypromellose; macrogol 4000

Mode d'administration:

Oral

Unités en paquet:

3 tablet

Type d'ordonnance:

(S4) Prescription Only Medicine

indications thérapeutiques:

Treatment of active rheumatoid arthritis. The combined use of leflunomide with other disease modifying antirheumatic drugs (DMARDs) has not been adequately studied (see Precautions).

Descriptif du produit:

Visual Identification: White, oblong biconvex tablets with a scoreline on one side; Container Type: Blister Pack; Container Material: PA/Al/PVC/Al - polyamide-aluminium foil-polyvinylchloride/aluminium foil; Container Life Time: 3 Years; Container Temperature: Store below 30 degrees Celsius

Statut de autorisation:

Licence status A

Date de l'autorisation:

2014-04-02